A claims construction hearing in Amgen Inc.’s patent infringement
lawsuit against Teva Pharmaceuticals USA, Inc., Teva
Pharmaceutical Industries Ltd. and Barr Laboratories, Inc. is set
for Jan. 25 and Jan.…
provides in-depth news coverage of intellectual property lawsuits involving public companies with assets of USD $1 billion or more. Coverage focuses on the infringement of intellectual property rights (including patents, copyrights, trademarks, trade dress, trade secrets, and royalties) and corporate indemnification of intellectual property violations.